To comprehensively evaluate the function of CARζ/CPR41BB cells and to directly compare the in vivo antitumor activity of CART and CPR/CART with CD28 versus 41BB costimulation, we utilized an orthotopic xenograft model of LN229-GBM. This evidence concerns the gene CD28 and glioblastoma.